AQR Capital Management’s Larimar Therapeutics LRMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.24M | Buy |
428,488
+316,262
| +282% | +$914K | ﹤0.01% | 2073 |
|
|
2025
Q1 | $241K | Buy |
+112,226
| New | +$241K | ﹤0.01% | 2790 |
|
|
2024
Q4 | – | Sell |
-15,712
| Closed | -$103K | – | 2910 |
|
|
2024
Q3 | $103K | Buy |
15,712
+86
| +0.6% | +$563 | ﹤0.01% | 2654 |
|
|
2024
Q2 | $113K | Buy |
+15,626
| New | +$113K | ﹤0.01% | 2486 |
|
|
2019
Q3 | – | Sell |
-1,640
| Closed | -$23K | – | 2134 |
|
|
2019
Q2 | $23K | Sell |
1,640
-2,185
| -57% | -$30.6K | ﹤0.01% | 2051 |
|
|
2019
Q1 | $126K | Sell |
3,825
-1,748
| -31% | -$57.6K | ﹤0.01% | 2118 |
|
|
2018
Q4 | $331K | Buy |
5,573
+2,144
| +63% | +$127K | ﹤0.01% | 1937 |
|
|
2018
Q3 | $481K | Buy |
3,429
+2,099
| +158% | +$294K | ﹤0.01% | 1969 |
|
|
2018
Q2 | $163K | Buy |
+1,330
| New | +$163K | ﹤0.01% | 2251 |
|
|
2017
Q1 | – | Sell |
-3,579
| Closed | -$137K | – | 2223 |
|
|
2016
Q4 | $137K | Sell |
3,579
-7,296
| -67% | -$279K | ﹤0.01% | 2193 |
|
|
2016
Q3 | $432K | Buy |
+10,875
| New | +$432K | ﹤0.01% | 1988 |
|
|
2016
Q1 | – | Sell |
-3,575
| Closed | -$269K | – | 2257 |
|
|
2015
Q4 | $269K | Sell |
3,575
-1,563
| -30% | -$118K | ﹤0.01% | 2061 |
|
|
2015
Q3 | $1.97M | Buy |
+5,138
| New | +$1.97M | ﹤0.01% | 1134 |
|